Articles dans des revues avec comité de lecture (111)
  1. 95. Jourdain, S., Drèze, P.-A., Vandeven, J., Verhaegen, J., Van Melderen, L., & Smeesters, P. (2011). Sequential multiplex PCR assay for determining capsular serotypes of colonizing S. pneumoniae. BMC infectious diseases, 11, 100. doi:10.1186/1471-2334-11-100
  2. 96. Smeesters, P., Deghorain, M., & Steer, A. C. (2011). Science that "knows" and science that "asks". Journal of translational medicine, 9, 128. doi:10.1186/1479-5876-9-128
  3. 97. McMillan, D. J., Kaul, S. Y., Bramhachari, P. V., Smeesters, P., Vu, T., Karmarkar, M. G., Shaila, M. S., & Sriprakash, K. S. (2011). Recombination drives genetic diversification of Streptococcus dysgalactiae subspecies equisimilis in a region of streptococcal endemicity. PloS one, 6(8), e21346. doi:10.1371/journal.pone.0021346
  4. 98. Smeesters, P., Cadar, S., Drèze, P.-A., Campos, D., & Van Melderen, L. (2010). Polyclonal dissemination of tetracycline resistance among Streptococcus pyogenes paediatric isolates from Brazil. Journal of Infection in Developing Countries, 4(11), 704-711.
  5. 99. Joachim, L., Campos, D., & Smeesters, P. (2010). Pragmatic scoring system for pharyngitis in low-resource settings. Pediatrics, 126(3), e608-e614. doi:10.1542/peds.2010-0569
  6. 100. Sablier, F., Slaouti, T., Drèze, P.-A., Fouly, P., Allemeersch, D., Van Melderen, L., & Smeesters, P. (2010). Nosocomial transmission of necrotising fasciitis. Lancet, 375(9), 1052. doi:10.1016/S0140-6736(10)60052-9
  7. 101. Smeesters, P., McMillan, D. J., & Sriprakash, K. S. (2010). The streptococcal M protein: a highly versatile molecule. Trends in microbiology. doi:10.1016/j.tim.2010.02.007
  8. 102. Smeesters, P., Dramaix Wilmet, M., & Van Melderen, L. (2010). The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS. Vaccine, 28(4), 883-885. doi:10.1016/j.vaccine.2009.10.137
  9. 103. Smeesters, P., McMillan, D. J., Sriprakash, K. S., & Georgousakis, M. M. (2009). Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? Expert review of vaccines, 8(12), 1705-1720. doi:10.1586/erv.09.133
  10. 104. Smeesters, P., Drèze, P.-A., Perez-Morga, D., Biarent, D., Van Melderen, L., & Vergison, A. (2009). Group A Streptococcus virulence and host factors in two toddlers with rheumatic fever following toxic shock syndrome. International journal of infectious diseases, 14(5), 403-409. doi:10.1016/j.ijid.2009.06.025
  11. 105. Murphy, T. F., Bakaletz, L. O., & Smeesters, P. (2009). Microbial interactions in the respiratory tract. The Pediatric infectious disease journal, 28(10 Suppl), S121-S126. doi:10.1097/INF.0b013e3181b6d7ec
  12. 106. Smeesters, P., Vergison, A., Junior, D. C., & Van Melderen, L. (2009). Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations. International journal of antimicrobial agents, 34(1), 44-49. doi:10.1016/j.ijantimicag.2009.01.012
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>